Nuwiq recombinant and Oritavancin Diphosphate
Determining the interaction of Nuwiq recombinant and Oritavancin Diphosphate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Nuwiq (recombinant)
Generic Name: oritavancin
Brand name: Orbactiv
Synonyms: Oritavancin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Nuwiq recombinant-Oritavancin Intravenous
- Nuwiq recombinant-Orkambi
- Nuwiq recombinant-Orkambi (Lumacaftor and Ivacaftor Granules)
- Nuwiq recombinant-Orkambi (Lumacaftor and Ivacaftor Tablets)
- Nuwiq recombinant-Orlistat
- Nuwiq recombinant-Ornex
- Oritavancin Diphosphate-NuZole
- Oritavancin Diphosphate-Nuzyra
- Oritavancin Diphosphate-Nuzyra (Omadacycline Injection)
- Oritavancin Diphosphate-Nuzyra (Omadacycline Tablets)
- Oritavancin Diphosphate-Nuzyra Intravenous
- Oritavancin Diphosphate-Nuzyra oral/injection